EPCAM and neoplasm: Additionally, a microfluidic-based strategy to develop hierarchical silica–magnetic microflowers with multilayered structures from a miniaturized five-run spiral-shaped microreactor, and to subsequently conjugate the EpCAM antibody on the surface, has been shown to exhibit high capture rates toward MCF-7 tumor cells from whole blood samples [95].